含有产生无毒百日咳毒素分子的百日咳博德特氏菌菌株的细胞百日咳疫苗。
Cellular pertussis vaccine containing a Bordetella pertussis strain that produces a nontoxic pertussis toxin molecule.
作者信息
Marsili I, Pizza M, Giovannoni F, Volpini G, Bartalini M, Olivieri R, Rappuoli R, Nencioni L
机构信息
Sclavo Research Center, Siena, Italy.
出版信息
Infect Immun. 1992 Mar;60(3):1150-5. doi: 10.1128/iai.60.3.1150-1155.1992.
Abstract
Bordetella pertussis 165-9K/129G, which produces a nontoxic form of pertussis toxin (PT), was used to prepare a whole-cell diphtheria-tetanus-pertussis (DTP) vaccine. The in vivo potency and the serological response induced by this vaccine were comparable to those of the conventional DTP vaccine which contains active PT. The toxic activities induced by PT such as leukocytosis, histamine sensitivity, and potentiation of anaphylactic reactions, which are present in the conventional DTP vaccine, were absent in the new vaccine. These results suggest that the introduction of a whole-cell vaccine containing B. pertussis 165-9K/129G would induce the same immunity as the conventional vaccine and would avoid the administration of a harmful toxin to children.
摘要
百日咳博德特氏菌165 - 9K/129G可产生无毒形式的百日咳毒素（PT），用其制备了全细胞白喉-破伤风-百日咳（DTP）疫苗。该疫苗诱导的体内效力和血清学反应与含有活性PT的传统DTP疫苗相当。传统DTP疫苗中存在的由PT诱导的毒性活性，如白细胞增多、组胺敏感性和过敏反应增强，在新疫苗中不存在。这些结果表明，引入含有百日咳博德特氏菌165 - 9K/129G的全细胞疫苗将诱导与传统疫苗相同的免疫力，并避免给儿童施用有害毒素。
相似文献
1
Cellular pertussis vaccine containing a Bordetella pertussis strain that produces a nontoxic pertussis toxin molecule.含有产生无毒百日咳毒素分子的百日咳博德特氏菌菌株的细胞百日咳疫苗。
Infect Immun. 1992 Mar;60(3):1150-5. doi: 10.1128/iai.60.3.1150-1155.1992.
2
Mucosal and systemic immunogenicity of a recombinant, non-ADP-ribosylating pertussis toxin: effects of formaldehyde treatment.一种重组非 ADP 核糖基化百日咳毒素的黏膜和全身免疫原性：甲醛处理的影响。
Vaccine. 1995 Dec;13(17):1643-8. doi: 10.1016/0264-410x(95)00134-m.
3
Comparative safety and immunogenicity of an acellular versus whole-cell pertussis component of diphtheria-tetanus-pertussis vaccines in Senegalese infants.塞内加尔婴儿中白喉-破伤风-百日咳疫苗的无细胞与全细胞百日咳成分的比较安全性和免疫原性。
Eur J Clin Microbiol Infect Dis. 1996 Dec;15(12):927-32. doi: 10.1007/BF01690510.
4
[The development of a new generation of pertussis vaccine].[新一代百日咳疫苗的研发]
Zh Mikrobiol Epidemiol Immunobiol. 1990 Oct(10):89-94.
5
Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice.表达百日咳毒素S1亚基的重组牛分枝杆菌卡介苗可诱导小鼠抵抗百日咳博德特氏菌脑内攻击。
Infect Immun. 2000 Sep;68(9):4877-83. doi: 10.1128/IAI.68.9.4877-4883.2000.
6
[A polyvalent complex of Bordetella pertussis antigens as the basis for an acellular pertussis vaccine].[一种以百日咳博德特氏菌抗原多价复合物为基础的无细胞百日咳疫苗]
Zh Mikrobiol Epidemiol Immunobiol. 1997 May-Jun(3):70-2.
7
Determination of circulating antibodies directed to pertussis toxin and of agglutinogens in children vaccinated with either the whole cell or component pertussis vaccine in France, Japan and Senegal.在法国、日本和塞内加尔，对接种全细胞百日咳疫苗或组分百日咳疫苗的儿童体内针对百日咳毒素的循环抗体及凝集原进行测定。
Vaccine. 1991 Nov;9(11):843-50. doi: 10.1016/0264-410x(91)90224-t.
8
A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.两种无细胞百日咳疫苗和一种全细胞百日咳疫苗的对照试验。百日咳项目工作组。
N Engl J Med. 1996 Feb 8;334(6):341-8. doi: 10.1056/NEJM199602083340601.
9
Progress towards the development of new vaccines against whooping cough.新型百日咳疫苗研发进展
Vaccine. 1992;10(14):1027-32. doi: 10.1016/0264-410x(92)90112-w.
10
Comparative study of a whole-cell pertussis vaccine and a recombinant acellular pertussis vaccine. The Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine.
J Pediatr. 1994 Jun;124(6):921-6. doi: 10.1016/s0022-3476(05)83181-6.
引用本文的文献
1
Development of vaccines at the time of COVID-19.2019冠状病毒病疫情期间疫苗的研发
Microlife. 2020 Dec 17;1(1):uqaa003. doi: 10.1093/femsml/uqaa003. eCollection 2020 Jul.
2
Whole-cell but not acellular pertussis vaccines induce convulsive activity in mice: evidence of a role for toxin-induced interleukin-1beta in a new murine model for analysis of neuronal side effects of vaccination.全细胞百日咳疫苗而非无细胞百日咳疫苗可诱导小鼠惊厥活动：在一种用于分析疫苗接种神经元副作用的新小鼠模型中，毒素诱导的白细胞介素-1β发挥作用的证据。
Infect Immun. 2001 Jul;69(7):4217-23. doi: 10.1128/IAI.69.7.4217-4223.2001.
3
Role of pertussis toxin A subunit in neutrophil migration and vascular permeability.百日咳毒素A亚基在中性粒细胞迁移和血管通透性中的作用。
Infect Immun. 1997 Mar;65(3):1114-8. doi: 10.1128/IAI.65.3.1114-1118.1997.
4
Biology of chemokine and classical chemoattractant receptors: differential requirements for adhesion-triggering versus chemotactic responses in lymphoid cells.趋化因子与经典趋化性受体的生物学特性：淋巴细胞中黏附触发与趋化反应的不同需求
J Cell Biol. 1996 Jul;134(1):255-66. doi: 10.1083/jcb.134.1.255.
5
Rapid G protein-regulated activation event involved in lymphocyte binding to high endothelial venules.快速的G蛋白调节激活事件参与淋巴细胞与高内皮微静脉的结合。
J Exp Med. 1993 Jul 1;178(1):367-72. doi: 10.1084/jem.178.1.367.
6
Depression of liver metabolism and induction of cytokine release by diphtheria and tetanus toxoids and pertussis vaccines: role of Bordetella pertussis cells in toxicity.
Infect Immun. 1994 Jan;62(1):29-32. doi: 10.1128/iai.62.1.29-32.1994.
7
Construction of a diphtheria toxin A fragment-C180 peptide fusion protein which elicits a neutralizing antibody response against diphtheria toxin and pertussis toxin.构建一种能引发针对白喉毒素和百日咳毒素的中和抗体反应的白喉毒素A片段-C180肽融合蛋白。
Infect Immun. 1992 Dec;60(12):5071-7. doi: 10.1128/iai.60.12.5071-5077.1992.
本文引用的文献
1
A Table Determining L.D.50 or the Fifty Per Cent End-Point.一张确定半数致死量（LD50）或50%终点的表格。
Proc Natl Acad Sci U S A. 1943 Jul;29(7):207-12. doi: 10.1073/pnas.29.7.207.
2
Pertussis vaccine and serious acute neurological illness in children.百日咳疫苗与儿童严重急性神经疾病
Br Med J (Clin Res Ed). 1981 Jun 13;282(6280):1968-9. doi: 10.1136/bmj.282.6280.1968.
3
Pertussis immunisation and serious acute neurological illness in children.儿童百日咳免疫接种与严重急性神经系统疾病
Br Med J (Clin Res Ed). 1981 May 16;282(6276):1595-9. doi: 10.1136/bmj.282.6276.1595.
4
Induction of a novel morphological response in Chinese hamster ovary cells by pertussis toxin.百日咳毒素诱导中国仓鼠卵巢细胞产生一种新的形态学反应。
Infect Immun. 1983 Jun;40(3):1198-203. doi: 10.1128/iai.40.3.1198-1203.1983.
5
Effect of pertussigen on inflammation caused by Freund adjuvant.百日咳菌苗原液对弗氏佐剂所致炎症的影响。
Infect Immun. 1984 Jun;44(3):637-41. doi: 10.1128/iai.44.3.637-641.1984.
6
Separation and purification of the hemagglutinins from Bordetella pertussis.百日咳博德特氏菌血凝素的分离与纯化
Infect Immun. 1983 Jul;41(1):313-20. doi: 10.1128/iai.41.1.313-320.1983.
7
Biological activities of crystalline pertussigen from Bordetella pertussis.百日咳博德特氏菌结晶性百日咳毒素的生物学活性
Infect Immun. 1981 Sep;33(3):820-6. doi: 10.1128/iai.33.3.820-826.1981.
8
Monoclonal antibody against pertussis toxin: effect on toxin activity and pertussis infections.抗百日咳毒素单克隆抗体：对毒素活性和百日咳感染的影响。
Infect Immun. 1984 Nov;46(2):422-8. doi: 10.1128/iai.46.2.422-428.1984.
9
A simple chemically defined medium for the production of phase I Bordetella pertussis.一种用于生产I相百日咳博德特氏菌的简单化学成分明确的培养基。
J Gen Microbiol. 1970 Oct;63(2):211-20. doi: 10.1099/00221287-63-2-211.
10
Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. I. Studies on factors affecting the toxin and antitoxin titration.使用VERO细胞测定白喉毒素和抗毒素效价的微细胞培养方法。I. 影响毒素和抗毒素滴定的因素研究。
J Biol Stand. 1974 Jul;2(3):189-201. doi: 10.1016/0092-1157(74)90015-8.
Zotero 插件